enGene Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $311.2M
Liabilities Breakdown FY2024
Total Liabilities: $38.6M
Asset Breakdown
Total Assets: $311.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $173.0M | 55.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.2M | 0.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $137.0M | 44.0% |
Liabilities Breakdown
Total Liabilities: $38.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 3.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $37.2M | 96.3% |